OTCBB:BIVI

Biovie Stock Insider Trading

etoro logo Buy BIVI
*Your capital is at risk
$1.65
-0.0500 (-2.94%)
At Close: Jun 03, 2026

BioVie Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.84. In total, the insiders bought 5.55M and sold 408.21K BIVI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.84
Buy 5.55M shares
Sell 408.21K shares
76% Buy Activity
Weak Negative Correlation
Buy Signal High Confidence
Jun 01, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 99.84.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (76% buys).

Historical Insider Trades

Date Type Person Role Amount
Dec 20, 2024
Buy
Stock Option (right to buy)
A-Award
Do Cuong V
President & CEO
CEO / President 104 502
Value: $198.6K
Dec 20, 2024
Buy
Stock Option (right to buy)
A-Award
Kim Joanne Wendy
Chief Financial Officer
C-Suite Officer 14 417
Value: $27.4K
Dec 20, 2024
Buy
Stock Option (right to buy)
A-Award
Palumbo Joseph M
Chief Medical Officer
Officer 15 417
Value: $29.3K
Dec 20, 2024
Buy
Stock Option (right to buy)
A-Award
Hariri Robert J
Director
Director 21 815
Value: $41.4K
Dec 20, 2024
Buy
Stock Option (right to buy)
A-Award
Lang James Paul
Director
Director 22 690
Value: $43.1K
Dec 20, 2024
Buy
Stock Option (right to buy)
A-Award
Sherman Michael Edward
Director
Director 23 325
Value: $44.3K
Dec 20, 2024
Buy
Stock Option (right to buy)
A-Award
Berman Richard J
Director
Director 23 155
Value: $44.0K
Dec 20, 2024
Buy
Stock Option (right to buy)
A-Award
Rogich Sigmund
Director
Director 22 070
Value: $41.9K
Nov 20, 2024
Buy
Common Stock
A-Award
Rogich Sigmund
Director
Director 32 700
Value: $109.9K
Nov 20, 2024
Buy
Common Stock
A-Award
Berman Richard J
Director
Director 34 200
Value: $114.9K
Nov 20, 2024
Buy
Stock Option (right to buy)
A-Award
Sherman Michael Edward
Director
Director 56 900
Value: $191.2K
Nov 20, 2024
Buy
Stock Option (right to buy)
A-Award
Lang James Paul
Director
Director 61 600
Value: $207.0K
Nov 20, 2024
Buy
Stock Option (right to buy)
A-Award
Hariri Robert J
Director
Director 49 800
Value: $167.3K
Nov 20, 2024
Buy
Stock Option (right to buy)
A-Award
Hariri Robert J
Director
Director 49 800
Value: $167.3K
Nov 20, 2024
Buy
Stock Option (right to buy)
A-Award
Lang James Paul
Director
Director 61 600
Value: $207.0K
Nov 20, 2024
Buy
Stock Option (right to buy)
A-Award
Sherman Michael Edward
Director
Director 56 900
Value: $191.2K
Nov 20, 2024
Buy
Common Stock
A-Award
Berman Richard J
Director
Director 34 200
Value: $114.9K
Nov 20, 2024
Buy
Common Stock
A-Award
Rogich Sigmund
Director
Director 32 700
Value: $109.9K
Jun 24, 2024
Buy
Stock Option (right to buy)
A-Award
Palumbo Joseph M
Chief Medical Officer
Officer 156 000
Value: $73.9K
Jun 24, 2024
Buy
Common Stock
A-Award
Palumbo Joseph M
Chief Medical Officer
Officer 116 000
Value: $549.8K
Jun 24, 2024
Sell
Common Stock
F-InKind
Palumbo Joseph M
Chief Medical Officer
Officer 29 000
Value: $13.7K
Jun 24, 2024
Buy
Common Stock
A-Award
Kim Joanne Wendy
Chief Financial Officer
C-Suite Officer 73 000
Value: $346.0K
Jun 24, 2024
Buy
Stock Option (right to buy)
A-Award
Kim Joanne Wendy
Chief Financial Officer
C-Suite Officer 99 000
Value: $46.9K
Jun 24, 2024
Sell
Common Stock
F-InKind
Kim Joanne Wendy
Chief Financial Officer
C-Suite Officer 18 250
Value: $9K
Jun 24, 2024
Buy
Common Stock
A-Award
Do Cuong V
President & CEO
CEO / President 168 000
Value: $796.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BIOVIE INC
BioVie
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE